Elevated soluble programmed death-ligand 1 levels indicate immunosuppression and poor prognosis in hepatocellular carcinoma patients undergoing transcatheter arterial chemoembolization.
Clin Chim Acta
; 511: 67-74, 2020 Dec.
Article
in En
| MEDLINE
| ID: mdl-32979338
Key words
Full text:
1
Database:
MEDLINE
Main subject:
Chemoembolization, Therapeutic
/
Carcinoma, Hepatocellular
/
Liver Neoplasms
Type of study:
Prognostic_studies
Limits:
Humans
Language:
En
Year:
2020
Type:
Article